Yokogawa releases OpreX Quality Management System to accelerate DX in quality assurance processes for the manufacturing of pharmaceuticals and food & beverages

Yokogawa Electric Corporation announces the release today of OpreX™ Quality Management System, a product in the OpreX Operational Risk Management family.

Delix plans further trials with neuroplastogen after positive Phase I data – Pharmaceutical Technology

DLX-001 is a neuroplastogen designed to promote neuroplasticity without giving rise to the deleterious attributes of first- and second-generation psychedelics. Credits: 15Studio/Shutterstock.com Delix Therapeutics is

July 15, 2024

New technique enhances understanding of chromatin organization

Researchers at the University of California San Diego Center for Epigenomics (C4E) have developed a new technique, called Droplet Hi-C, that allows scientists to rapidly

October 18, 2024

Shredding the Medicaid safety net

There is every indication that incoming President Trump and congressional leadership will look to slash federal health care spending — primarily Medicaid — to pay for

January 16, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.